Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» The Best- And Worst-Performing Biotech Stocks, Feb. 21 to Feb. 28
The Best- And Worst-Performing Biotech Stocks, Feb. 21 to Feb. 28
The Best- And Worst-Performing Biotech Stocks, Feb. 21 to Feb. 28
Submitted by
admin
on March 3, 2014 - 8:12am
Source:
Forbes
News Tags:
InterMune
Prana Biotechnology
Cara Therapeutics
Prothena
Endologix
Ampio Pharmaceuticals
Questcor Pharmaceuticals
Aegerion
Headline:
The Best- And Worst-Performing Biotech Stocks, Feb. 21 to Feb. 28
Do Not Allow Advertisers to Use My Personal information
